- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
No quiz today.
Current Top Players:
1) Dr. James Bucci
2) Dr. Richard Young
3) Dr. Peter Andrus
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (3679)
- More
- Other Specialty
Psychiatry - Schizophrenia/Psychosis News & Articles
MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.
Your Unread Messages in Psychiatry
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
Smartest Doc Challenge
MDLinx
Child and Adolescent Clinical Pearls -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Depression associated with poor outcomes in CVD patients -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest (5) Full Text Articles (406) Focus on General Psychiatry981 Associations between health risk behaviors and symptoms of schizophrenia and bipolar disorder: a systematic review General Hospital Psychiatry, October 18, 2012 Evidence Based Medicine Clinical Article
982 Plasma levels of D-serine in Brazilian individuals with schizophrenia Schizophrenia Research, October 18, 2012
983 Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects Biological Psychiatry, October 17, 2012 Evidence Based Medicine
984 Socioeconomic status and beliefs about depression, schizophrenia and eating disorders Social Psychiatry and Psychiatric Epidemiology, October 17, 2012
985 Is autism spectrum disorder common in schizophrenia? Psychiatry Research, October 17, 2012
986 Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status Social Psychiatry and Psychiatric Epidemiology, October 17, 2012
987 Classes of Psychotic Experiences in Kenyan Children and Adolescents Child Psychiatry and Human Development, October 17, 2012
988 Insight, psychopathology, explanatory models and outcome of schizophrenia in India: a prospective 5-year cohort study Full Text BMC Psychiatry, October 17, 2012
989 Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist Full Text Indian Journal of Psychiatry, October 16, 2012 Clinical Article
990 Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia Full Text Indian Journal of Psychiatry, October 16, 2012
991 Factor analysis of positive and negative syndrome scale in schizophrenia: An exploratory study Full Text Indian Journal of Psychiatry, October 16, 2012
992 Nicotine dependence and illness severity in schizophrenia The British Journal of Psychiatry, October 16, 2012
993 Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes Pharmacogenetics and genomics, October 16, 2012 Clinical Article
994 Rethinking the role of long-acting atypical antipsychotics in the community setting International Clinical Psychopharmacology, October 16, 2012
995 When Broca Goes Uninformed: Reduced Information Flow to Broca’s Area in Schizophrenia Patients With Auditory Hallucinations Schizophrenia Bulletin, October 16, 2012
996 The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia Schizophrenia Research, October 15, 2012
997 Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis Schizophrenia Bulletin, October 12, 2012
998 Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia Schizophrenia Research, October 12, 2012
999 Empathy in electrodermal responsive and nonresponsive patients with schizophrenia Schizophrenia Research, October 12, 2012
1000 The role of ethnicity in treatment refractory schizophrenia Comprehensive Psychiatry, October 11, 2012
Clinical Pearls in Psychiatry
- The three core symptoms of neuropsychiatric illness behavior in Alzheimer patients are depression, anxiety and apathy
- In institutionalized people with dementia the introduction of a motor and multisensory-based approach in care routines may improve residents' engagement and attention to the environment
- Decreased BMI might be a useful indicator for future risk of dementia in Parkinson’s disease patients
Highlights in Psychiatry
Risk factors for postpartum depression
As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).
Read the article summaryA link between cardiovascular fitness and depression
As published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).
Read the article summaryOptimal dose of amisulpride for acute exacerbation of schizophrenia
As published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).
Read the article summaryMost Popular Psychiatry Articles
Last month's top read Top Articles of 20121 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013 Evidence Based Medicine
2 Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials European Neuropsychopharmacology, April 29, 2013 Evidence Based Medicine Review Article
3 Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study Biological Psychiatry, April 5, 2013
4 The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial Schizophrenia Research, April 17, 2013
5 Long-term remission in schizophrenia and schizoaffective disorder: results from the risperidone long-acting injectable versus quetiapine relapse prevention trial Therapeutic Advances in Psychopharmacology, April 1, 2013
6 A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis Psychoneuroendocrinology, April 19, 2013 Evidence Based Medicine Review Article
7 Management of schizophrenia: clinical experience with asenapine Journal of Psychopharmacology, April 4, 2013
8 Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials European Archives of Psychiatry and Clinical Neuroscience, April 22, 2013 Evidence Based Medicine
9 Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study Schizophrenia Research, April 16, 2013
10 Categorical and dimensional approaches to negative symptoms of schizophrenia: Focus on long-term stability and functional outcome Schizophrenia Research, April 23, 2013
11 Treating Older Adults With Schizophrenia: Challenges and Opportunities Schizophrenia Bulletin, April 8, 2013 Review Article
12 Diagnostic Discontinuity in Psychosis: A Combined Study of Cortical Gyrification and Functional Connectivity Schizophrenia Bulletin, April 26, 2013
13
The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review
Therapeutic Advances in Psychopharmacology, March 1, 2013
Review Article
Exclusive Author Commentary
14 Effects of cannabis use status on cognitive function, in males with schizophrenia Psychiatry Research, April 3, 2013
15 Depressive symptoms in first episode psychosis: a one-year follow-up study BMC Psychiatry, April 9, 2013 Free full text
16 Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: A case-control study Journal of Psychiatric Research, April 24, 2013
17 Specific vs general cognitive remediation for executive functioning in schizophrenia: A multicenter randomized trial Schizophrenia Research, April 17, 2013
18 Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia International Clinical Psychopharmacology, April 25, 2013
19 Clinical high-risk state does not predict later psychosis in a delinquent adolescent population Early Intervention in Psychiatry, April 15, 2013
20 The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia Schizophrenia Research, April 1, 2013
Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction more
Other Topics in Psychiatry
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close